Real-World Evidence in the Pharmaceutical Landscape

Author:   Sunil Dravida ,  Abhishek Dabral ,  Jugal Sharma
Publisher:   Gatekeeper Press
ISBN:  

9781662914089


Pages:   288
Publication Date:   29 October 2021
Format:   Hardback
Availability:   Available To Order   Availability explained
We have confirmation that this item is in stock with the supplier. It will be ordered in for you and dispatched immediately.

Our Price $131.87 Quantity:  
Add to Cart

Share |

Real-World Evidence in the Pharmaceutical Landscape


Overview

Full Product Details

Author:   Sunil Dravida ,  Abhishek Dabral ,  Jugal Sharma
Publisher:   Gatekeeper Press
Imprint:   Gatekeeper Press
Dimensions:   Width: 15.20cm , Height: 2.40cm , Length: 22.90cm
Weight:   0.676kg
ISBN:  

9781662914089


ISBN 10:   1662914083
Pages:   288
Publication Date:   29 October 2021
Audience:   General/trade ,  General
Format:   Hardback
Publisher's Status:   Active
Availability:   Available To Order   Availability explained
We have confirmation that this item is in stock with the supplier. It will be ordered in for you and dispatched immediately.

Table of Contents

Reviews

Author Information

Sunil Dravida is a Managing Director at NTT Data Services leading the life sciences practice. He has over 30 years of extensive experience in executive management, data and analytics, platform engineering, artificial intelligence, and machine learning. He has worked with many of the world's largest and fastest-growing pharmaceutical and biotech companies and has a relentless passion for improving patient outcomes by leading digital transformation in healthcare. Sunil is an expert in R&D, clinical and Real-World Data and works directly with clients on their RWD/RWE strategies and advanced analytics projects across various groups, including R&D, drug development, medical affairs, HEOR, and market access. Abhishek Dabral is a leader in the clinical data science space with over 16 years of industry experience in the intersection of statistical programming and data management. He has led teams to implement industry best practices, clinical programming efficiencies, streamlining operations, data standards implementation, governance, data strategy, and innovation. He has extensive experience working across disparate data sources, therapeutic areas, and R&D functions and has worked on many NDA (New Drug Applications) filings, which FDA/EMA/PMDA has successfully approved. Jugal Sharma, Dr. Qin Ye and Charan Kumar Kuyyamudira have all co-authored this book. Jugal is a data architect with a growing start-up, and he has worked in the healthcare domain for more than a decade. He has worked in the Managed Market, with Real-World Data, and in the regulatory area of healthcare. He is a data geek, and he often shares his knowledge and expertise about healthcare on social media. Dr. Qin Ye is the Global RWE lead for ZS. Qin has been focusing on helping clients realize the value of their RWD investment in R&D to leverage ZS's strategy, data science, and technology capabilities. In his role, Qin leads the development of the RWE team, oversees the development of innovative RWE offerings, and works directly with clients on evidence generation and advanced data sciences programs across clinical, HEOR, medical, and market access functions. Charan Kumar Kuyyamudira is the Director of Operations at Ephicacy, Bangalore, India. Charan has over 16 years of experience in life sciences and has worked for different organizations, including Novartis, IQVIA, and Accenture, in various capacities. He has authored several papers at global conferences, including PharmaSUG, PHUSE, and SCDM. His area of interest includes RWE studies, service and risk management, AI-ML implementation, robotics, green energy, and its implications in operations.

Tab Content 6

Author Website:  

Countries Available

All regions
Latest Reading Guide

NOV RG 20252

 

Shopping Cart
Your cart is empty
Shopping cart
Mailing List